Australia markets closed

CytoDyn Inc. (CYDY)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.1440-0.0020 (-1.37%)
As of 11:46AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 145.03M
Enterprise value 174.11M
Trailing P/E N/A
Forward P/E 10.81
PEG ratio (5-yr expected) N/A
Price/sales (ttm)761.84
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA -3.82

Trading information

Stock price history

Beta (5Y monthly) 0.19
52-week change 3-48.28%
S&P500 52-week change 321.08%
52-week high 30.4200
52-week low 30.1300
50-day moving average 30.1698
200-day moving average 30.1901

Share statistics

Avg vol (3-month) 32.57M
Avg vol (10-day) 31.16M
Shares outstanding 5993.37M
Implied shares outstanding 6993.37M
Float 8979.97M
% held by insiders 10.80%
% held by institutions 10.02%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 May 2023
Most-recent quarter (mrq)29 Feb 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-76.29%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -15.17M
Net income avi to common (ttm)-53.17M
Diluted EPS (ttm)-0.0600
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.4M
Total cash per share (mrq)0
Total debt (mrq)30.49M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.08
Book value per share (mrq)-0.12

Cash flow statement

Operating cash flow (ttm)-12.74M
Levered free cash flow (ttm)6.84M